Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
31 neželeni učinki iz pomarketinškega obdobja
adverse reactions from post-marketing experience
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
med obdobjem pomarketinškega nadzora so bili opisani naslednji neželeni učinki.
the following adverse events have been reported during post-marketing surveillance.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
neželeni učinki, morda ali verjetno povezani s cidofovirjem na podlagi kliničnih preskušanj in pomarketinškega spremljanja
adverse reactions possibly or probably related to cidofovir based on clinical trial experience and post-marketing surveillance
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
neželeni učinki iz pomarketinškega obdobja med pomarketinškim obdobjem uporabe zdravila sutent so zabeležili naslednje vrste učinkov.
adverse reactions from post-marketing experience
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
neželeni učinki vključujejo tudi tiste, ki so jih poročali iz pomarketinškega spremljanja bolnikov, ki so jemali cialis po potrebi.
adverse reactions are also included that have been reported from postmarketing surveillance in patients taking cialis on demand.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
podatki o varnosti iz študije pomarketinškega nadzora v zda pri 9829 bolnikih, ki so dobivali nutropin ali nutropinaq, kažejo, da je mogoče z zdravilom povezane neželene reakcije pričakovati pri približno 2% bolnikov.
safety data from 9829 patients treated with nutropin or nutropinaq - derived from a post-marketing surveillance survey in the united states - demonstrate that approximately 2% of patients have been shown to experience drug-related adverse reactions.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
neželeni učinki ocene pogostnosti: zelo pogosti (≥ 1/ 10), pogosti (≥ 1/ 100 do < 1/ 10), občasni (≥ 1/ 1000 do < 1/ 100), redki (≥ 1/ 10. 000 do < 1/ 1000), zelo redki (< 1/ 10. 000) in ni znano (ocena neželenih učinkov, ki jih niso poročali v registracijskih preskušanjih, ni možna iz poročil pomarketinškega spemljanja).
very common (≥ 1/ 10), common (≥ 1/ 100 to < 1/ 10), uncommon (≥ 1/ 1000 to < 1/ 100), rare (≥ 1/ 10,000 to < 1/ 1000), very rare (< 1/ 10,000) and not known (events not reported in registration trials cannot be estimated from postmarketing spontaneous reports)
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
Warning: Contains invisible HTML formatting